MEIRAGTX HOLDINGS PLC

(MGTX)
  Report
Delayed Nasdaq  -  03:52 2022-08-17 pm EDT
9.800 USD   -6.84%
08/12Chardan Research Trims MeiraGTx Holdings Price Target to $46 From $47, Maintains Buy Rating
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 2024
MT
08/11MEIRAGTX HOLDINGS PLC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Linked Retinitis Pigmentosa Patients

06/28/2022 | 08:12am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON 0.14% 167.84 Delayed Quote.-2.05%
MEIRAGTX HOLDINGS PLC -6.84% 9.8 Delayed Quote.-55.69%
All news about MEIRAGTX HOLDINGS PLC
08/12Chardan Research Trims MeiraGTx Holdings Price Target to $46 From $47, Maintains Buy Ra..
MT
08/11MeiraGTx's Q2 Net Loss Per Diluted Share Widens; Expects Sufficient Capital Through Q4 ..
MT
08/11MEIRAGTX HOLDINGS PLC Management's Discussion and Analysis of Financial Condition and ..
AQ
08/11MEIRAGTX : Reports Second Quarter 2022 Financial and Operational Results - Form 8-K
PU
08/11MeiraGTx Reports Second Quarter 2022 Financial and Operational Results
GL
08/11MeiraGTx Holdings plc Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/10NORTH AMERICAN MORNING BRIEFING : Caution -2-
DJ
08/04MEIRAGTX : Announces Financing Agreement with Perceptive Advisors for Up to $100 Million S..
PU
08/04MEIRAGTX HOLDINGS PLC : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
08/03MeiraGTx Says it Gets $100 Million Term Loan From Perceptive Advisors; MeiraGTx Shares ..
MT
More news
Analyst Recommendations on MEIRAGTX HOLDINGS PLC
More recommendations
Financials (USD)
Sales 2022 43,9 M - -
Net income 2022 -103 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,49x
Yield 2022 -
Capitalization 470 M 470 M -
Capi. / Sales 2022 10,7x
Capi. / Sales 2023 9,48x
Nbr of Employees 333
Free-Float 71,9%
Chart MEIRAGTX HOLDINGS PLC
Duration : Period :
MeiraGTx Holdings plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEIRAGTX HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 10,52 $
Average target price 31,14 $
Spread / Average Target 196%
EPS Revisions
Managers and Directors
Alexandria Forbes President, Chief Executive Officer & Director
Richard Giroux Chief Operating & Financial Officer
Keith Reginald Harris Director
Robert K. Zeldin Chief Medical Officer
Ellen Hukkelhoven Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEIRAGTX HOLDINGS PLC-55.69%470
GILEAD SCIENCES, INC.-8.65%82 985
VERTEX PHARMACEUTICALS37.98%78 356
REGENERON PHARMACEUTICALS, INC.2.72%68 773
WUXI APPTEC CO., LTD.-23.26%40 492
BIONTECH SE-37.79%39 486